<?xml version="1.0" encoding="UTF-8"?>
<p>The drug-likeness properties of the standard drugs and selected medicinal plant bioactives were screened using Lipinskiâ€™s rule of five (RO5; 
 <ext-link ext-link-type="uri" xlink:href="http://www.scfbio-iitd.res.in/software/drugdesign/lipinski.jsp" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.scfbio-iitd.res.in/software/drugdesign/lipinski.jsp</ext-link>; Lipinski, 
 <xref rid="CIT0031" ref-type="bibr">2004</xref>). Additional drug-likeness features, including lipophilicity, solubility and the drug-likeness score of the ligands were obtained using OSIRIS Property Explorer (
 <ext-link ext-link-type="uri" xlink:href="https://www.organic-chemistry.org/prog/peo/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.organic-chemistry.org/prog/peo/</ext-link>) and the SWISSADME server (
 <ext-link ext-link-type="uri" xlink:href="http://www.swissadme.ch/" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.swissadme.ch/</ext-link>; Daina et al., 
 <xref rid="CIT0009" ref-type="bibr">2017</xref>).
</p>
